We should talk about all the things that are a threat to our existence so that we can have the best practices to try to mitigate risk and avoid those if at all possible
Fail to see the clinical impact other than on diabetics who are now struggling to get their medication
Ending compounding makes sense legally and, for safety reasons, the FDA would prefer that people receive medications from approved drug makers
Structural plasticity associated with exposure to drugs of abuse
In: Modern Trends in Human Leukemia IV, 73-76, 1981
Such an ideal unimolecular antidiabetic agent should have complementary effects correcting multiple pathophysiological defects of T2D and be safe, durable, well-tolerated, easy to administer, and cost-effective